Suven Life Sciences informs about press release
Date: 07-12-2015Suven Life Sciences has informed about a Press Release dated December 07, 2015 titled ‘Suven Initiates Phase 2A trial of SUVN-502 in USA in Alzheimers Disease’.
The above information is a part of company’s filings submitted to BSE.